Editas Medicine (EDIT) Total Liabilities (2015 - 2025)

Editas Medicine (EDIT) has 11 years of Total Liabilities data on file, last reported at $159.2 million in Q4 2025.

• Quarterly Total Liabilities fell 23.19% year-over-year to $159.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $159.2 million (down 23.19% YoY) and the FY2025 annual result came in at $159.2 million, down 23.19% from the prior year.
• Total Liabilities declined to $159.2 million in Q4 2025 per EDIT's latest filing, from $188.3 million in the prior quarter.
• Across five years, Total Liabilities topped out at $207.3 million in Q4 2024 and bottomed at $110.3 million in Q1 2022.
• The 5-year median for Total Liabilities is $146.3 million (2023), against an average of $150.8 million.
• The widest annual swing landed in 2021, when Total Liabilities sank 38.71%; it then surged 38.16% in 2024.
• Tracing EDIT's Total Liabilities over 5 years: stood at $123.8 million in 2021, then grew by 24.06% to $153.6 million in 2022, then declined by 2.33% to $150.1 million in 2023, then surged by 38.16% to $207.3 million in 2024, then fell by 23.19% to $159.2 million in 2025.
• Per Business Quant, the three latest EDIT Total Liabilities figures stand at $159.2 million (Q4 2025), $188.3 million (Q3 2025), and $191.4 million (Q2 2025).

Peer Comparison